Isotretinoin iPLEDGE REMS Proposed Revisions To Get Two-Day AdComm Review

 
• By Brenda Sandburg
  
Isotretinoin
FDA panel to discuss proposed changes to the Risk Evaluation and Mitigation Strategy for isotretinoin • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers